Video

Understanding Cancer's Financial Landscape

Author(s):

Ashley Johnson, patient wellness navigator at Charleston Hematology and Oncology Associates, discusses how important it is for the whole health care team to better understand insurance and how patients pay for their cancer treatment.

Ashley Johnson, patient wellness navigator at Charleston Hematology and Oncology Associates, discusses how important it is for the whole health care team to better understand insurance and how patients pay for their cancer treatment.

Johnson participated in the ACCC Financial Advocacy Bootcamp, which helped provide a more in-depth knowledge of how to better help patients navigate through the financial landscape during their cancer treatment. She discussed her experience at the ACCC 34th National Oncology Conference.

Related Videos
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
There was no evidence that CAR T directly caused secondary malignancies, despite FDA warnings, citing prior treatments as the cause, according to research.
Image of woman with black hair.
Image of man with black hair.
Related Content